Edwards Life Sciences Corp. (EW): Today's Featured Health Care Loser

Edwards Life ( EW) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 0.4%. By the end of trading, Edwards Life fell $1.40 (-1.6%) to $84.05 on average volume. Throughout the day, 1.5 million shares of Edwards Life exchanged hands as compared to its average daily volume of 1.2 million shares. The stock ranged in price between $83.43-$86 after having opened the day at $86 as compared to the previous trading day's close of $85.45. Other company's within the Health Care sector that declined today were: ProPhase Labs ( PRPH), down 34.5%, Graymark Healthcare ( GRMH), down 27.9%, Response Genetics ( RGDX), down 18.7%, and Fonar Corporation ( FONR), down 15.8%.

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases or critically ill patients worldwide. Edwards Life has a market cap of $9.72 billion and is part of the health services industry. The company has a P/E ratio of 42.3, below the average health services industry P/E ratio of 42.9 and above the S&P 500 P/E ratio of 17.7. Shares are up 20.9% year to date as of the close of trading on Wednesday. Currently there are 10 analysts that rate Edwards Life a buy, no analysts rate it a sell, and nine rate it a hold.

TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the positive front, Repros Therapeutics ( RPRX), up 31.6%, Cell Therapeutics ( CTIC), up 14.8%, Keryx Biopharmaceuticals ( KERX), up 13.1%, and Accelr8 Technology Corporation ( AXK), up 12.7%, were all gainers within the health care sector with Biogen Idec ( BIIB) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

If you liked this article you might like

Edwards Lifesciences: Cramer's Top Takeaways

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Hold on Concert's Hair Loss Trials Pushes Shares Down 10%

Edwards Lifesciences Is Not Skipping A Beat

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock